Weight Loss, Appetite Suppression, and Changes in Fasting and Postprandial Ghrelin and Peptide-YY Levels After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: A Prospective, Double Blind Study

By S. Karamanakos, K. Vagenas, F. Kalfarentzos, T. Alexandrides. Annals of Surgery, 2008

889 citations recorded by the source corpus.

Subfields: Endocrine and Autonomic Systems, Surgery

View Paper: https://www.semanticscholar.org/paper/84901bb9a7983550a89f010b832dd15ff1b682fc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrine and Autonomic Systems

1. I. S. Farooqi

In Surgery

1. J. Dobbeleir
2. G. Peeters
3. J. Himpens

Citations in the corpus

• Long-term Results of Laparoscopic Sleeve Gastrectomy for Obesity (2010, background): “One patient died of colon cancer 4 years after LSG. Gastroesophageal complaints were reported after TABLE 1.”
• Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial (2018, methodology): “Exploratory clinical end points were (1) changes in comorbidities (arterial hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, gastroesophageal reflux, arthralgia, depression, and hyperuricemia; assessed by a physician at each visit); (2) quality of life assessed on the Gastrointe”
• Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. (2017, positive): “both RYGB and VSG decrease the orexigenic hormone ghrelin (87, 378, 379) and increase the anorexogenic incretins glucagon-like peptide 1 and peptide YY (380, 381), thus decreasing appetite and improving insulin sensitivity (382).”